The Forefront of Clinical
Neuro-Diagnosis

FDA

90% of Strokes & 35% of Dementias are Preventable

HP background

Direct ElectroPhysiology Imaging

The First Non-Invasive Probe
for Direct Brain Network Visualization

Delphi·MD Probes brain health by directly ‘pinging’ brain network and tracking its response in a safe, objective manner.
The Technology >
Delphi
Objective & direct
Objective & Direct
Fully automated & real-time
Fully Automated
& Real-Time
Applicable in any clinical setting
Applicable in Any
Clinical Setting
Extremely accurate
Extremely Accurate
Highly sensitive
Highly Sensitive
Safe & Accessible
Safe & Accessible

Certifications:

FDA Breakthrough Designation
FDA Breakthrough
Designation

* Delphi-MD is not approved for commercial use in the United States

CE Marked
CE Marked

* Delphi-MD is not approved for commercial use in the United States

ISO 13485 Certified
ISO 13485
Certified

* Delphi-MD is not approved for commercial use in the United States

Delphi·MD in the Clinic

Patient lays comfortably
Patient Lays
Comfortably
Delphi·MD probes brain network function
Delphi·MD Probes
Brain Network
Function
Delphi·MD output Report is produced
Delphi·MD
Output Report
is Produced
Neurologist performs Early detection and diagnosis
Neurologist Performs
Early Detection
and Diagnosis
HP Clinic

Confidence Through Evidence

Delphi·MD in Stroke and TBI

Evaluation of White Matter Integrity Utilizing the Delphi·MD System. Front Neurosci. 2020 Dec 21;14:589107.

Read More >
Delphi·MD in stroke and TBI

Delphi·MD for Detection of Healthy VS Unhealthy Brain Ageing

Introducing a Novel Approach for Evaluation & Monitoring of Brain Health Across Life Span Using Direct Non-invasive Brain Network Electrophysiology. Front Aging Neurosci. 2019 Sep 9;11:248.

Read More >
Delphi·MD for detection of Healthy vs unhealthy brain aging

Delphi·MD in Parkinson’s Disease

A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson’s disease, Parkinsonism & Related Disorders, Parkinsonism related dis. 2021 Jun 18 ; 89:28;

Read More >
Delphi·MD in Parkinson’s disease

Delphi·MD as Early Dementia \ Alzheimer’s Biomarker

Brain Network Integrity Changes in Subjective Cognitive Decline,  a Possible Physiological Biomarker of Dementia Journal: Fronti Neurology. 2021 July

Read More >
Delphi·MD as Early dementia \Alzheimer’s Biomarker

News & Events

October 28th

4th Annual NIA-AA Symposium

The Event >

October 2021

The 13th World Stroke Organization

The Event >
HP News background

Contact Us

    Application

    Neuro
    Diagnostics

    Contact
    logo

    © 2021 Quantalx Neuroscience, Inc. All Rights Reserved.

    Branding & Website by TitanBrandWise

    Skip to content